286 related articles for article (PubMed ID: 22507807)
21. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
[TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid syndrome.
Lim W
Hematology Am Soc Hematol Educ Program; 2013; 2013():675-80. PubMed ID: 24319251
[TBL] [Abstract][Full Text] [Related]
23. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome.
Khogeer H; Alfattani A; Al Kaff M; Al Shehri T; Khojah O; Owaidah T
Lupus; 2015 Feb; 24(2):186-90. PubMed ID: 25253571
[TBL] [Abstract][Full Text] [Related]
24. TLC immunostaining for detection of "antiphospholipid" antibodies.
Conti F; Alessandri C; Spinelli FR; Capozzi A; Martinelli F; Recalchi S; Misasi R; Valesini G; Sorice M
Methods Mol Biol; 2014; 1134():95-101. PubMed ID: 24497357
[TBL] [Abstract][Full Text] [Related]
25. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
Asherson RA
Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
[TBL] [Abstract][Full Text] [Related]
26. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
27. Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies.
Owaidah TM; Qurashi FH; Al Nounou RM; Al Zahrani H; Al Mussa A; Tbakhi AI; Al Daama S; Elkum N; Roberts GT
Hematology; 2003 Aug; 8(4):249-57. PubMed ID: 12911943
[TBL] [Abstract][Full Text] [Related]
28. Interpretation and recommended testing for antiphospholipid antibodies.
Galli M
Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
[TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid syndrome.
George D; Erkan D
Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604
[TBL] [Abstract][Full Text] [Related]
30. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome.
Zou X; Fan Z; Zhao L; Xu W; Zhang J; Jiang Z
BMC Gastroenterol; 2021 Apr; 21(1):148. PubMed ID: 33794795
[TBL] [Abstract][Full Text] [Related]
32. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
[TBL] [Abstract][Full Text] [Related]
33. Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.
Rangel ML; Alghamdi I; Contreras G; Harrington T; Thomas DB; Barisoni L; Andrews D; Wolf M; Asif A; Nayer A
Lupus; 2013 Jul; 22(8):855-64. PubMed ID: 23722230
[TBL] [Abstract][Full Text] [Related]
34. The antiphospholipid syndrome: from pathophysiology to treatment.
Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
[TBL] [Abstract][Full Text] [Related]
35. Which are the best biological markers of the antiphospholipid syndrome?
Carreras LO; Forastiero RR; Martinuzzo ME
J Autoimmun; 2000 Sep; 15(2):163-72. PubMed ID: 10968904
[TBL] [Abstract][Full Text] [Related]
36. Bleeding and thrombosis in a patient with secondary antiphospholipid syndrome.
Kaaroud H; Beji S; Guermazi S; Moussa FB; Hamida FB; Ezzine S; Abdallah TB; El Younsi F; Kheder A
Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):227-31. PubMed ID: 18310872
[TBL] [Abstract][Full Text] [Related]
37. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
38. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
39. The geoepidemiology of the antiphospholipid antibody syndrome.
Biggioggero M; Meroni PL
Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199
[TBL] [Abstract][Full Text] [Related]
40. Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome.
Vreede AP; Bockenstedt PL; McCune WJ; Knight JS
Curr Opin Rheumatol; 2019 May; 31(3):231-240. PubMed ID: 30747734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
